🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 13/06/2011 | 0,3626 USD |
| 11/03/2011 | 0,3626 USD |
| 13/12/2010 | 0,3626 USD |
| 13/09/2010 | 0,3626 USD |
| 11/06/2010 | 0,3626 USD |
| 11/03/2010 | 0,3626 USD |
| 11/12/2009 | 0,3626 USD |
| 02/09/2009 | 0,3626 USD |
| 04/06/2009 | 0,3626 USD |
| 04/03/2009 | 0,3626 USD |
| 03/12/2008 | 0,3626 USD |
| 03/09/2008 | 0,3626 USD |
| 04/06/2008 | 0,3626 USD |
| 05/03/2008 | 0,3626 USD |
| 05/12/2007 | 0,3626 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 09/08/2017 | 59,59 | 59,85 | 59,37 | 59,63 | +0,27% | 0,80% | 6.866.810 |
| 08/08/2017 | 59,68 | 59,85 | 59,35 | 59,47 | -0,83% | 0,83% | 8.048.745 |
| 07/08/2017 | 60,07 | 60,20 | 59,79 | 59,96 | -0,41% | 0,68% | 7.018.246 |
| 04/08/2017 | 60,72 | 60,77 | 60,06 | 60,21 | -0,66% | 1,18% | 5.597.368 |
| 03/08/2017 | 60,31 | 60,81 | 60,29 | 60,61 | +0,13% | 0,87% | 7.355.702 |
| 02/08/2017 | 61,02 | 61,03 | 60,28 | 60,53 | -0,75% | 1,24% | 7.372.575 |
| 01/08/2017 | 61,11 | 61,33 | 60,85 | 60,99 | +0,06% | 0,78% | 6.802.463 |
| 31/07/2017 | 61,31 | 61,36 | 60,60 | 60,95 | -0,36% | 1,25% | 12.277.215 |
| 28/07/2017 | 60,89 | 61,41 | 60,32 | 61,17 | +0,66% | 1,79% | 13.982.521 |
| 27/07/2017 | 60,75 | 61,59 | 59,92 | 60,77 | +3,06% | 2,75% | 22.894.922 |
| 26/07/2017 | 59,46 | 59,48 | 58,89 | 58,97 | -0,90% | 1,00% | 9.816.302 |
| 25/07/2017 | 59,97 | 60,11 | 59,40 | 59,50 | -0,34% | 1,19% | 6.241.783 |
| 24/07/2017 | 59,68 | 60,02 | 59,64 | 59,70 | -0,10% | 0,64% | 8.157.318 |
| 21/07/2017 | 59,91 | 60,11 | 59,71 | 59,76 | -0,49% | 0,67% | 7.237.907 |
| 20/07/2017 | 60,03 | 60,34 | 59,98 | 60,06 | +0,51% | 0,60% | 6.974.545 |
| 19/07/2017 | 59,64 | 59,95 | 59,58 | 59,75 | +0,34% | 0,62% | 5.972.657 |
| 18/07/2017 | 59,64 | 59,76 | 59,42 | 59,55 | -0,32% | 0,58% | 6.408.415 |
| 17/07/2017 | 60,26 | 60,41 | 59,67 | 59,74 | -0,71% | 1,24% | 7.741.890 |
| 14/07/2017 | 60,05 | 60,50 | 59,98 | 60,17 | +0,27% | 0,86% | 6.309.903 |
| 13/07/2017 | 59,91 | 60,11 | 59,43 | 60,01 | +0,18% | 1,13% | 7.125.562 |
| 12/07/2017 | 59,79 | 60,24 | 59,79 | 59,90 | +0,71% | 0,75% | 8.610.368 |
| 11/07/2017 | 59,94 | 60,10 | 59,39 | 59,48 | -0,78% | 1,18% | 7.207.620 |
| 10/07/2017 | 60,49 | 60,50 | 59,74 | 59,95 | -0,52% | 1,25% | 7.036.062 |
| 07/07/2017 | 60,31 | 60,44 | 59,93 | 60,27 | +0,10% | 0,84% | 7.591.083 |
| 06/07/2017 | 60,85 | 60,98 | 60,11 | 60,21 | -1,65% | 1,44% | 11.887.150 |
| 05/07/2017 | 61,52 | 61,83 | 60,99 | 61,22 | -0,17% | 1,36% | 6.820.174 |
| 03/07/2017 | 60,93 | 61,67 | 60,93 | 61,33 | +0,28% | 1,22% | 4.895.627 |
| 30/06/2017 | 61,54 | 61,77 | 61,07 | 61,15 | -0,39% | 1,13% | 8.762.223 |
| 29/06/2017 | 62,03 | 62,10 | 61,15 | 61,39 | -1,26% | 1,52% | 8.751.114 |
| 28/06/2017 | 62,75 | 62,88 | 62,16 | 62,18 | -0,58% | 1,16% | 7.056.498 |